| Jan Frances Care Center | |
| 815 North Country Club Road, Ada, Oklahoma 74820 | |
| (580) 332-5328 | |
| Name | Jan Frances Care Center |
|---|---|
| Location | 815 North Country Club Road, Ada, Oklahoma |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 132 |
| Occupancy Rate | 25.91% |
| Medicare ID (CCN) | 375243 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | Government - City/county |
| NPI Number | 1649267733 |
| Organization Name | JAN FRANCES CARE CENTER LLC |
| Doing Business As | JAN FRANCES CARE CENTER |
| Address | 815 N Country Club Rd, Ada, OK 74820 |
| Phone Number | 580-332-5328 |
News Archive
Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute along with MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Jasdaq Market of the Osaka Securities Exchange, today reported preliminary results of the company's neurological drug candidate, ibudilast (MN-166/AV411), in a Phase 1b/2a trial in opioid addicts. The study was largely funded by the National Institute on Drug Abuse (NIDA) with MediciNova supplementation.
Obesity and emotional problems, such as feelings of low mood and anxiety, tend to develop hand-in-hand from as young as age 7 years, according to new research being presented at this year's European Congress on Obesity in Glasgow, UK (28 April-1 May).
Although genome-wide analysis identified two genetic variations associated with Alzheimer disease, these variations did not improve the ability to predict the risk of AD, according to a study in the May 12 issue of JAMA.
The Bill & Melinda Gates Foundation today announced 76 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support researchers across 16 countries, including nine in Europe and Africa with ideas as diverse as using the power of sunlight to kill malaria-causing mosquito larvae and developing a device that repels mosquitoes without insecticides.
Professor Erich Wanker of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and of the Excellence Cluster Neurocure is to receive EUR 675 000 in funding from the Helmholtz Association over the next two years. The grant shall be used to accelerate the search for active agents to treat diseases that are caused by protein misfolding. These include Alzheimer's and Parkinson's.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute along with MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Jasdaq Market of the Osaka Securities Exchange, today reported preliminary results of the company's neurological drug candidate, ibudilast (MN-166/AV411), in a Phase 1b/2a trial in opioid addicts. The study was largely funded by the National Institute on Drug Abuse (NIDA) with MediciNova supplementation.
Obesity and emotional problems, such as feelings of low mood and anxiety, tend to develop hand-in-hand from as young as age 7 years, according to new research being presented at this year's European Congress on Obesity in Glasgow, UK (28 April-1 May).
Although genome-wide analysis identified two genetic variations associated with Alzheimer disease, these variations did not improve the ability to predict the risk of AD, according to a study in the May 12 issue of JAMA.
The Bill & Melinda Gates Foundation today announced 76 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support researchers across 16 countries, including nine in Europe and Africa with ideas as diverse as using the power of sunlight to kill malaria-causing mosquito larvae and developing a device that repels mosquitoes without insecticides.
Professor Erich Wanker of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and of the Excellence Cluster Neurocure is to receive EUR 675 000 in funding from the Helmholtz Association over the next two years. The grant shall be used to accelerate the search for active agents to treat diseases that are caused by protein misfolding. These include Alzheimer's and Parkinson's.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 5 |
| Total Amount of Fines in Dollars | $6500 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 5 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 29.57 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.08 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.05 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 6.1 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.48 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.44 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.51 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.63 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 30.88 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 34.71 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.6 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95 | 95.98 |